A research team in the US confirmed the effectiveness of three doses of quadrivalent human papillomavirus (HPV) vaccine among women aged 20 years and younger, however, more research is needed for women aged between 21-26 years.
Government advisors are recommending that the national HPV immunization programme in England should include both boys and girls. The Joint Committee of Vaccinations and Immunisations (JCVI) believes that this would be a cost-effective option for preventing HPV-related diseases in boys and further improves public health.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.